Autoimmune Diseases  >>  BHT-3021  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
BHT-3021 / Bayhill Therap
NCT00453375: Phase 1 Study of BHT-3021 in Subjects With Type 1 Diabetes Mellitus

Completed
1
80
US, RoW
BHT-3021, BHT-Placebo
Bayhill Therapeutics
Diabetes, Hypoglycemia
05/11
05/11

Download Options